SC 13G Filing

Company

Aptose Biosciences Inc.

Filed

November 16, 2010

Accession Number

0001178913-10-003032

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →